연구동향 분석

Clinicopatholgic Characteristics to the Relapse on Ductal Carcinoma In Situ: Ki-67 Index as the Most Influential Prognostic Factor

Minsuh Park Geumhee Gwak Jungbin Kim 조현진 Keunho Yang Yujin Lee Kyeongmee Park Jiyoung Kim Youngjoo Shin Yeyoung Seo 2022년

논문상세정보
인용/피인용
' Clinicopatholgic Characteristics to the Relapse on Ductal Carcinoma In Situ: Ki-67 Index as the Most Influential Prognostic Factor' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Breast neoplasms
  • ductalcarcinomainsitu
  • ki-67
  • recur-rence
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
575 0

0.0%

' Clinicopatholgic Characteristics to the Relapse on Ductal Carcinoma In Situ: Ki-67 Index as the Most Influential Prognostic Factor' 의 참고문헌

  • 유방암 검진 권고안 개정안
    이은혜 [2015]
  • Will oncotype DX DCIS testing guide therapy? A single-institution correlation of oncotype DX DCIS results with histopathologic findings and clinical management decisions
    Lin CY [2018]
  • The relationships between HER2 overexpression and DCIS characteristics
    Di Cesare P [2017]
  • Screening mammography mitigates breast cancer disparities through early detection of triple negative breast cancer
    Bayard S [2021]
  • Predictors of Recurrent Ductal Carcinoma In Situ after Breast-Conserving Surgery
    김정연 [2016]
  • Personalizing the treatment of women with early breast cancer : highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
  • Optimal Ki67 cut-off for luminal breast cancer prognostic evaluation : a large case series study with a long-term follow-up
    Bustreo S [2016]
  • Molecular phenotypes of DCIS predict overall and invasive recurrence
    Williams KE [2015]
  • Long-term Follow-up of Pure Ductal Carcinoma in situ after Breast-Conserving Surgery
  • Ki-67 expression as a factor predicting recurrence of ductal carcinoma in situ of the breast : a systematic review and meta-analysis
    Poulakaki N [2018]
  • Invasive lobular breast cancer : data to support surgical decision making
    Cocco D [2021]
  • Estrogen and progesterone receptor testing in breast cancer : ASCO/CAP guideline update
    Allison KH [2020]
  • Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ : long-term results from the UK/ANZ DCIS trial
    Cuzick J [2011]
  • Clinicopathological markers associated with recurrence in ductal carcinoma in situ of breast by age group
  • Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2016
    정규원 [2019]
  • Breast-conserving treatment with or without radiotherapy in ductal carcinoma in situ : 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial
    Donker M [2013]
  • Breast cancer–specific mortality after invasive local recurrence in patients with ductal carcinoma-in-situ of the breast
    Lee LA [2006]
  • Benefit of low-dose tamoxifen in a large observational cohort of high risk ER positive breast DCIS
  • Behaviour and characteristics of low-grade ductal carcinoma in situ of the breast : literature review and single-centre retrospective series
    Koh VCY [2019]
  • Annual report of cancer statistics in Korea in 2018
  • Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ(IBIS-II DCIS) : a double-blind, randomised controlled trial
    Forbes JF [2016]
  • APOBEC3B gene expression in ductal carcinoma in situ and synchronous invasive breast cancer